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The transforming proteinsencoded by adenovirus and
several other small DNA tumor viruses disturb host cell
growth control by interacting with cellular factors that
Summary normally function to repress cell proliferation. Adenovi-
rus E1A transforming activity resides in two distinct do-
PCAF histone acetylase plays a role in regulation of mains, the targets of which include p300/CBP and the
transcription, cell cycle progression, and differentia- retinoblastoma protein family (reviewed in Moran, 1993;
tion. Here, we show that PCAF is found in a complex Nevins, 1994; Eckner, 1996). While the RB pathway has
consisting of more than 20 distinct polypeptides. Strik- been well studied, the p300/CBP pathway had not been
ingly, some polypeptides are identical to TBP-asso- clarified until our lab cloned the novel histone acetylase
ciated factors (TAFs), which are subunits of TFIID. PCAF (Yang et al., 1996). Significantly, binding of E1A
Like TFIID, histone fold±containing factors are present to p300/CBP disturbs access of PCAF acetylase to
within the PCAF complex. The histone H3± and H2B± p300/CBP (Yang et al., 1996). In support of relevance
like subunits within the PCAF complex are identical to of this competition,PCAF and E1A compete in regulation
those within TFIID, namely, hTAFII31 and hTAFII20/15, of cell cycle progression, differentiation, and transcrip-
tional activation: exogenous expression of PCAF inHeLarespectively. The PCAF complex has a novel histone
cells inhibits cell cycle progression and counteracts theH4±like subunit with similarity to hTAFII80 that inter-
mitogenic activity of E1A (Yang et al., 1996). Exogenousacts with the histone H3±like domain of hTAFII31.
expression of PCAF inmyoblasts promotes MyoD-medi-Moreover, the PCAF complex has a novel subunit with
ated p21 expression and terminal cell cycle arrest. Con-WD40 repeats having a similarity to hTAFII100.
versely, E1A inhibits activation of the myogenic program
through competition with PCAF for access to p300/CBPIntroduction
(Puri et al., 1997).
PCAF consists of a C-terminal GCN5-related region
A central question in eukaryotic transcription is how the with intrinsic histone acetylase activity and an N-termi-
transcriptional machinery gains access to specific loci nal PCAF-specific region that interacts with p300/CBP
tightly packed in chromatin. One mechanism is believed (Yang et al., 1996). Interestingly, PCAF interacts with the
to involve histone acetylation. The nucleosome core con- other histone acetylases, namely, p300/CBP (Yang et
sists of 1.75 turns of DNA wrapped around an octameric al., 1996) and ACTR/Src1 (Chen et al., 1997; Spencer et
complex comprising two H2A-H2B heterodimers and al., 1997), forming an acetylase complex on promoter
two H3-H4 heterodimers. Each histone has a C-terminal elements. Of particular significance, myogenic tran-
histone fold domain and an N-terminal basic tail that is scription and differentiation are dependent on the his-
thought to stabilize the nucleosomal structure through tone acetylase activity of PCAF but not on that of p300/
interactions with DNA. In addition, recent crystallo- CBP (Puri et al., 1997). Similarly, requirements for spe-
graphic studies of mononucleosomes revealed the di- cific acetylase activity have been examined in other sys-
rect interaction of histone tails to adjacent nucleosomes, tems, yielding results consistent with distinct roles for
suggesting a role of histone tails inhigh ordered chroma- individual histone acetylases (Korzus et al., 1998).
tin structure (Luger et al., 1997). Histone acetylases Here, to investigate PCAF function at the molecular
modify specific lysines within the N-terminal tail of core level in greater detail, we purified PCAF in its native
state. PCAF is found in a complex with more than 20histones and thereby neutralize the positive charges.
associated polypeptides, including counterparts of yeastThis leads to destabilization of the chromatin structure
(y) ADA2, yADA3, and ySPT3, which are associated inand increases the accessibility of transcription factors
the yGCN5-containing complex (Grant et al., 1997). Moreto the nucleosomal DNA (reviewed in Grunstein, 1997;
strikingly, some polypeptides associated with PCAF areLuger et al., 1997; Wade and Wolffe, 1997; Mizzen and
identical to the histone fold±containing TBP-associated
factors (TAFs), which are subunits of TFIID (Kokubo et³To whom correspondence should be addressed.
al., 1994; Hoffmann et al., 1996; Nakatani et al., 1996;§These authors contributed equally to this work.
Xie et al., 1996; for review, see Burley and Roeder, 1996).‖ Present address: Molecular Oncology Group, Royal Victoria, Hos-
Furthermore, some polypeptides show significant se-pital Room H5.37, McGill University, 687, Pine Avenue West, Mon-
treal, Quebec H3A 1A1. quence similarity to other TAFs. Taken together, these
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PCAF. Cells were transduced with recombinant retrovi-
rus expressing a bicistronic mRNA encoding FLAG-
PCAF (f:PCAF) linked to an ILR2 a subunit surface
marker (Ziran et al., unpublished data), and the trans-
duced subpopulation was purified by repeated cycles
of affinity cell sorting. Nuclear extract was prepared
from the resulting cells and fractionated on S-Sepha-
rose. More than 80% of recovered f:PCAF from the col-
umn was detected in the 0.3 M KCl fraction. The epitope-
tagged PCAF was purified from this fraction by affinity
chromatography on anti-FLAG antibody±conjugated aga-
rose. The bound polypeptides were eluted with the epi-
tope peptide under native conditions (Figure 1, lane 2).
As a control, we performed mock purification from a
nuclear extract prepared from nontransduced HeLa cells
(lane 1). While many polypeptides specific to f:PCAF
expressing cells were identified at this purification level,
f:PCAF was further purified by anti-PCAF antibody affin-
ity chromatography. Polypeptides retained on the resin
were eluted by denaturing with SDS. After this second
affinity purification, almost all nonspecific polypeptides
bound to anti-FLAG antibody agarose were removed
(compare lane 1 to lanes 3 and 4), and more than 20
polypeptides that associate with PCAF were identified
(lanes 5 and 6). Note that the 30 kDa and 25 kDa bands,
which migrate near the light chain of immunoglobulin
on the SDS-PAGE gel, were identified to be specific to
the PCAF complex after the firstaffinity-purification step
Figure 1. Purification of the PCAF Complex
(lane 2). Purification of the PCAF complex fraction is
The PCAF complex was purified from a nuclear extract prepared
summarized in Table 1. At present, it is not clear whetherfrom f:PCAF-expressing HeLa cells (lanes 2, 4, and 6). As a control,
this complex is uniform or heterogeneous.we performed mock purification from a nuclear extract prepared
from nontransduced HeLa cells (lanes 1, 3, and 5). The PCAF com-
plex was immunoprecipitated on anti-FLAG antibody-conjugated Histone Acetylase Activity in the PCAF Complex
agarose from the S-Sepharose-0.3 M KCl fraction, and the bound We next tested the acetylase activity of the PCAF com-
materials were eluted with the epitope peptide (lanes 1 and 2). The plexusing either free corehistones (Figure 2A) or nucleo-
eluates were further purified by anti-PCAF antibody affinity chroma- somes (Figure 2B) as substrates. Assays were performed
tography, and both unbound (lanes 3 and 4) and bound (lanes 5 and
with various concentrations of either recombinant PCAF6) fractions are shown. Proteins were resolved by SDS-PAGE and
or the PCAF complex ranging from 0.25 to 1 pmol ofstained with Coomassie brilliant blue. The polypeptides specific to
PCAF. When free histones were used as a substrate,the fraction purified from the f:PCAF-expressing cells are indicated.
Positions of the heavy and light chainsof IgG are shownby asterisks. both the recombinant PCAF (Figure 2A [bottom], lanes
2±5) and the PCAF complex (lanes 6±9) strongly acet-
ylated histone H3 and weakly modified histone H4, with
results suggest the presence of a histone octamer±like the level of acetylation of the latter being moderately
structure within the PCAF complex, as previously shown higher for the complex. In contrast, when nucleosomes
in TFIID. were used as substrates, the level of acetylation by
the PCAF complex was substantially higher (Figure 2B,
Results lanes 6±9) than that by recombinant PCAF (lanes 2±5).
The acetylation of histone H3 by the PCAF complex was
Purification of the PCAF Complex even stronger than that by a molar excess of recombi-
To facilitate purification of the PCAF complex, we first nant p300, previously reported to be the strongest his-
tone acetylase catalytic subunit (Ogryzko et al., 1996)established HeLa cells expressing FLAG epitope±tagged
Table 1. Purification of the PCAF Complex
Specific Activity
Proteina (mg) f:PCAFb (U) (U/mg protein) Fold Purification
Nuclear extract 1760 200 0.11 1
S Sepharose 220 120 0.54 4.9
anti-FLAG affinity 0.18 20 110 1000
anti-PCAF affinity 0.06 10 170 1500
a Total protein was determined by using the BioRad protein kit except that total protein in the anti-PCAF affinity-purified protein was estimated
from a Coomassie blue±stained gel with BSA as a standard.
b Relative amount of f:PCAF was determined by immunoblotting with anti-FLAG antibody and shown as Western units.
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(lane 11). While p300 was strongly autoacetylated (Fig-
ures 2A [bottom] and 2B, lane 11), only weak autoacety-
lation was observed in both recombinant PCAF and the
PCAF complex (Figures 2A and 2B, lanes 2±5). However,
interestingly, a 53 kDa band in the PCAF complex was
acetylated (Figures 2A [bottom] and 2B, lanes 6±9). Con-
trol reactions performed with control complex fraction
(Figures 2A and 2B, lane 10) or without enzyme (Figures
2A and 2B, lane 1) displayed no detectable histone acet-
ylase activity. These data suggest that additional sub-
unit(s) in the PCAF complex may facilitate the PCAF-
mediated acetylation of core histones in a nucleosomal
context, although we cannot exclude the possibility that
an additional catalytic subunit might be present in the
complex.
ADA and SPT Counterparts
in the PCAF Complex
We used mass spectrometry to identify proteins in the
PCAF complex. Specific protein bands from Coomassie
blue±stained SDS-PAGE gels (z1±3 pmol/band) were
excised, destained, digested with trypsin in the pres-
ence of 50% [18O]-water to label the C termini of the
tryptic peptides (Qin et al., 1998), and the resulting pep-
tides were extracted as described (Zhang et al., 1998).
Five percent of the extracted peptides sufficed to ac-
quire a MALDI/TOF spectrum, after which z20%±50%
of the sample was used to obtain LC/MS/MS spectra.
The MS/MS spectra were used to search the compiled
NCBI nonredundant protein database and ESTdatabase
with the program PepFrag to identify the proteins (FenyoÈ
et al., 1998). One MS/MS spectrum from the 53 kDa
band identified the protein hADA2 (GenBank AF069732)
(Candau et al., 1996) (Figure 3A). Nineteen tryptic pep-
tides can be assigned to this protein within a mass
accuracy of 10 ppm in the MALDI/TOF spectrum ob-
tained for the 53 kDa band (Table 2). This combination of
MS/MS and peptide mapping data ensures high fidelity
protein identification (FenyoÈ et al., 1998).
Another MS/MS spectrum from the same band indi-
cated the presence of a second unresolved protein,
identified by four mouse EST clones that contain the
same sequence of IQEYEFTDDPIDVPR (Figure 3B). Da-
tabase searches using as query the encoded DNA se-
quences from these EST clones identified a human EST
clone encoding an entire open reading frame (GenBank
gi:770769). An encoded polypeptide sequence shows
sequence similarity with yADA3 with significant gaps
Figure 2. Histone Acetylase Activity in the PCAF Complex (25% identity and 45% similarity) (Figure 3C). Thirty tryp-
tic fragments deduced from the translated sequenceThe histone acetylase activity was measured using either free core
histones (A) or nucleosomes (B) as substrates. Acetylase assays were assigned to the MALDI/TOF spectrum within a
were performed with BSA (lane 1), recombinant PCAF (lanes 2±5), mass accuracy of 10 ppm, and MS/MS spectra were
the PCAF complex (lanes 6±9), the mock purified control (lane 10), obtained from eight of them (Table 2). These results
and recombinant p300 (lane 11). The total protein concentration in
confirm that the second identified cDNA encodes anthe reaction was normalized by adding BSA. The amount of PCAF
hADA3-like subunit in the PCAF complex.in the complex was normalized to the recombinant by Coomassie
blue staining, and assays were performed with 0.25 pmol (lanes 2 In the same fashion, we identified EST clones for the
and 6), 0.5 pmol (lanes 3 and 7), 0.75 pmol (lanes 4 and 8), and 1
pmol (lanes 5 and 9) of PCAF. A volume of the mock-purified control
fraction that was normalized to the largest amount of PCAF complex
of p300, PCAF, BSA and each of the core histones are indicated.used (lane 6) was assayed. After separation by SDS-PAGE, the gel
was stained with Coomassie brilliant blue (top), then acetylated The position of the acetylated 53 kDa band of the PCAF complex
is indicated with an asterisk. Note that acetylation of free histoneshistones were detected by autoradiography (bottom). Only the auto-
radiograph is shown in (B), but the corresponding Coomassie by recombinant p300 resulted in a quantitative shift of the histones
to slightly higher mobility, perhaps due to hyperacetylation.stained gel is nearly identical to the one shown in (A). The positions
Cell
38
37 kDa band. Some of these clones exhibit similarity to
ySPT3. We determined the entire sequence of one iso-
late (GenBank gi:2336227), which revealed that the
translated sequence displays similarity to ySPT3 through
its entire coding region with several gaps (30% identity
and 51% similarity) (Figure 3D). Eighteen tryptic frag-
ments could be assigned to the MALDI/TOF spectrum,
and two MS/MS spectra were obtained (Table 2). These
results indicate the identity of an additional cDNA en-
coding a bona fide subunit of the PCAF complex.
TAFs in the PCAF Complex
The 34, 30, 22, and 16 kDa bands were determined to
be human (h) TAFII31, hTAFII30, hTAFII20, and hTAFII15,
respectively (Table 2), which are known to be TBP-
associated factors that are subunits of TFIID (reviewed
in Burley and Roeder, 1996). To exclude the possibility
that detection of these TAFs was the result of contam-
ination by TFIID, we analyzed the PCAF complex and
TFIID by immunoblotting (Figure 4). hTAFII250, hTAFII130,
hTAFII100, hTAFII80, and hTBP were present specifically
in the TFIID fraction, whereas PCAF was detected spe-
cifically in the PCAF complex. On the other hand,
hTAFII31, hTAFII30, hTAFII20, and hTAFII15 were detected
in both the PCAF complex and TFIID. Intriguingly, the
PCAF complex has two polypeptides that react with
anti-hTAFII31 antibody (i.e., a faster migrating form that
comigrates with hTAFII31 in TFIID and a slower migrating
form that is specific to the PCAF complex). Consistent
with a previous report (Jacq et al., 1994), anti-hTAFII30
antibody reacts with two polypeptides in TFIID that mi-
grate very closely on an SDS-PAGE gel. Similarly, these
two polypeptides were detected by anti-hTAFII30 anti-
body in the PCAF complex. hTAFII20 and hTAFII15 are
products generated from the same gene by alternative
splicing such that the latter form lacks the N-terminal
region of hTAFII20 (Hoffmann and Roeder, 1996). Like
TFIID, the PCAF complex contains both hTAFII20 and
hTAFII15. Taken together, these results indicate that mul-
tiple TAFs are bona fide subunits of the PCAF complex.
Histone Octamer±like Structure
in the PCAF Complex
The N-terminal regions of hTAFII80 and hTAFII31 have
sequence similarity with histones H4 and H3, respec-
tively, forming a histone tetramer±like structure (re-
viewed in Burley and Roeder, 1996). The C-terminal re-
gion of hTAFII20 (or hTAFII15) has weak similarity with
histone H2B and forms a homodimer (Hoffmann et al.,
1996). These observations, together with the stoichiom-
Figure 3. ADA- and SPT-like Factors in the PCAF Complex etry of this set of TAFs in TFIID, have led us to propose
(A) Mass spectrometric sequencing of the tryptic peptide encoding that there is a histone octamer±like structure within the
hADA2. The MS/MS spectrum identifies a protein in the 53 kDa band TFIID complex that is composed of two dimers of
as hADA2. The y and b ions are C- and N-terminal ions, respectively hTAFII20/hTAFII15 attached to a tetramer of hTAFII80 and(Biemann, 1988).
hTAFII31 (reviewed in Burley and Roeder, 1996; Hoff-(B) Mass spectrometric sequencing of the tryptic peptide encoding
mann et al., 1996). It is particularly intriguing that thethe hADA3-like subunit (hADA3). The MS/MS spectrum identifies
four mouse EST clones that contain the sequence shown in the PCAF complex has a subset of histone-like TAFs,
figure. Ions are identified as in (A). namely, hTAFII31, hTAFII20, and hTAFII15 (Figure 4 and
(C) Deduced amino acid sequence of hADA3 and its alignment to Table 2). Although immunoblotting analysis demon-
yADA3. Identical and related amino acids are shaded.
strates that hTAFII80 is not in the PCAF complex (Figure(D) Deduced amino acid sequence of the hSPT-like subunit (hSPT3)
4), the 65 kDa band contains a novel polypeptide withand its alignment to ySPT3. Identical and related amino acids are
shaded. similarity to hTAFII80 (24% identity and 42% similarity),
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Table 2. Identification of PCAF Associated Factors by Mass Spectrometry
No. of
Peptides
Band Protein Assigned Peptide Sequences for which MS/MS Spectra Were Obtained
P65 PAF65a 13 8RFVEIPR14, 62KLTVEDFNR70, 205SVSHDLEQLHRLLQVAR221,
577LFQTAFPAPYGPSPASR593
P65 PAF65b 23 123FHGMFLQNASQK134, 167LQEDSYNYLIR177
P53 hADA2 19 361SAPPLNLTGLPGTEK375
P53 hADA3a 30 89DHELGAPPK97, 125NLQPK129, 130IQEYEFTDDPIDVPR144,
200WAQEDLLEQK210, 224GLMGPLTELDTK235, 370LAKEEVSR377,
422ERESILK428, 424ESILK428
P37 hSPT3a 18 109VITPEDLLFLMR120, 329IGPLSPFTNAYR340
P34 hTAFII31 15 25DMGITEYEPR34, 35VINQMLEFAFR45, 46VVTTILDDAK55,
79ADQSFTSPPPR89, 176VGTPMSLTGQR186, 187FTVQMPTSQSPAVK200,
223NILITTNMMSSQNTANESSNALKR246
P30 hTAFII30 5 43ASPAGTAGGPGAGAAAGGTGPLAAR67
P22 hTAFII20 4 50LSPENNQVLTK60, 115DVQLHLER122
P16 hTAFII15 2 85DVQLHLER92
a The hADA3-like and hSPT3-like subunits are referred to as hADA3 and hSPT3, respectively.
referred to as PCAF-associated factor (PAF) 65a (Figure with theWD40 repeat±containing TAF (yTAFII90, a homo-
log of hTAFII100) (M. J. Swanson and Y. N., unpublished5A and Table 2). Importantly, the N-terminal histone-
like regions are well conserved between PAF65a and observations). While the PCAF complex does not in-
clude hTAFII100 (Figure 4), the 65 kDa band containshTAFII80 (Figure 5B).
Next, we tested whether the histone-like domain of a novel polypeptide with similarity to hTAFII100 (46%
identity and 58% similarity), referred to as PAF65b (Fig-PAF65a interacts with that of hTAFII31 (Figure 5C). The
histone H4±like region of PAF65a (residues 12±86) and ure 5D). WD40 repeats appear in proteins involved in
signal transduction, gene regulation, vesicle fusion, andhistone H3±like region of hTAFII31 (residues 5±89) were
expressed independently in Escherichia coli as GST- cytoskeletal assembly (reviewed in Neer et al., 1994).
The crystallographic structure of the G-protein b subunitand His-tagged proteins, respectively. Extracts pre-
pared with buffer containing 6 M guanidine were mixed revealed that the WD40 repeats form a circularized
b-propeller structure (Wall et al., 1995; Sondek et al.,at an equimolar ratio of recombinant proteins and core-
natured by dialyzing with buffer containing 0.1 M guani- 1996). Although the biological function of WD40 repeats
is uncertain, they are well conserved between PAF65bdine (Nakatani et al., 1996). The protein complex was
purified by glutathione-Sepharose chromatography fol- and hTAFII100 (Tanese et al., 1996; Tao et al., 1997).
Both contain six completerepeats (WD40-1 and WD40-3lowed by Ni21-NTA agarose chromatography. The his-
tone H4±like region of P65a and histone H3±like region to -7; see Figure 5D) and one incomplete repeat (WD40-2).
of hTAFII31 were copurified through these chromato-
graphic steps (lanes 4 and 7) but not in controls including Similar Subunit Composition between
the PCAF and hGCN5 Complexesonly a single extract (lanes 5, 6, 8, and 9). Similar results
were obtained by Ni21-NTA agarose chromatography fol- hGCN5 is highly homologous to the C-terminal region
of PCAF (Yang et al., 1996) (Figure 6A). To test whetherlowed by glutathione-Sepharose chromatography (lanes
10±15). hGCN5 forms a similar complex to PCAF, we purified
the hGCN5 complex from HeLa cells stably expressingYeast suppressor screening revealed that yTAFII60, a
homolog of the H4-like hTAFII80, genetically interacts FLAG epitope±tagged hGCN5 (f:hGCN5) (Figure 6B).
Figure 4. Identification of TAFs in the PCAF Complex
Equimolar amounts of the PCAF complex (middle lanes) and TFIID (Chiang et al., 1993) (right lanes), as well as the mock-purified control for
the PCAF complex (left lanes) were resolved by SDS-PAGE, transferred to nitrocellulose membrane, and blotted against various antibodies
as indicated at the top of each panel.
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f:hGCN5 was directly purified from the extract by anti-
FLAG antibody affinity chromatography (lane 3) followed
by anti-hGCN5 antibody affinity chromatography (lane
7). Importantly, almost identical sets of associated poly-
peptides were observed in the hGCN5 and PCAF com-
plexes, judging from their molecular weights on an SDS-
PAGE gel (compare lanes 2 and 3, and lanes 5 and 7).
We confirmed the presence of the ADA2-like subunit
and hTAFII31 inboth complexes by immunoblotting (data
not shown). These results suggest that the C-terminal
region of PCAF, which is homologous to hGCN5, could
be responsible for all PCAF complex interactions.
No Association of p300/CBP with the Histone
Octamer±like Structure
Since both the PCAF and TFIID complexes have histone
fold±containing factors (reviewed in Burley and Roeder,
1996) and intrinsic histone acetylase activity (Mizzen et
al., 1996), we tested whether the histone octamer±like
structure is a common feature of histone acetylase com-
plexes. We immunoprecipitated p300/CBP from a HeLa
nuclear extract and determined whether hTAFII31 is co-
precipitated (Figure 7). Although PCAF interacts with
p300/CBP, this interaction is far from stoichiometric and
relatively unstable in extracts (Yang et al., 1996). More-
over, the interaction between PCAF and p300/CBP is
hardly detected in HeLa nuclear extract (Y. N., unpub-
lished observations), perhaps due to the presence of
endogenous papillomavirus E7 that may disturb the in-
teraction between PCAF and p300/CBP, like adenovirus
E1A. In fact, neither p300 nor CBP was detected in
the purified PCAF complex by immunoblotting (data not
shown). Consistently, neither anti-p300 noranti-CBP an-
tibody precipitated detectable PCAF (lanes 3 and 4) or
vice versa (lane 2). While anti-PCAF antibody coprecipi-
tated hTAFII31 along with PCAF, neither anti-p300 nor
anti-CBP antibody coprecipitated hTAFII31 (lanes 3 and
4). Thus, we conclude that neither p300 nor CBP is
present as a complex with a histone octamer±like struc-
ture that includes hTAFII31.
Discussion
The PCAF Complex and the Yeast
SAGA ComplexFigure 5. Novel TAF-like Factors in the PCAF Complex
Yeast GCN5 is found in at least two distinct multimeric(A) Deduced amino acid sequence of PAF65a and its alignment to
hTAFII80. Identical and related amino acids are shaded. protein complexes, ADA and SAGA. Both complexes
(B) Sequence similarity between PAF65a, TAFs, and histone H4. contain yADA2 and yADA3, but the latter complex addi-
Sequence similarity with histone H4 is found only in the N-terminal
tionally contains SPT3, SPT7, and SPT20 (Grant et al.,regions of PAF65a and indicated TAFs. The a-helical and loop re-
1997). As expected from the sequence conservation be-gions assigned from the X-ray structure of dTAFII62 within the tetra-
meric complex (Xie et al., 1996) are indicated. tween yGCN5 and PCAF, subunits with similarity to
(C) Interaction between the histone-like regions of PAF65a and yADA2, yADA3, and ySPT3 are found in the PCAF com-
hTAFII31. GST-PAF65a (aa 12±86) and His-hTAFII31(aa 5±89) were plex. Although counterparts for ySPT7 and ySPT20 haveexpressed independently as inclusion bodies in E. coli and corena-
not been identified to date in the PCAF complex, wetured as described previously (Nakatani et al., 1996) (lane 1). Con-
trols including only a single extract were also prepared (lanes 2 suspect that corresponding polypeptides might be found
and 3). These samples (lanes 1±3) were purified by glutathione- among the unidentified subunits.
Sepharose chromatography (lanes 4±6) followed by Ni21-NTA aga-
Although the yGCN5 catalytic subunit alone cannotrose chromatography (lanes 7±9). Similarly, these samples (lanes
acetylate nucleosomal substrates, both ADA and SAGA1±3) were also purified by Ni21-NTA agarose chromatography
(lanes 10±12) followed by glutathione-Sepharose chromatography complexes can effectively acetylate histones in nucleo-
(lanes 13±15). Proteins were separated by SDS-PAGE and stained somes (Grant et al.,1997). Consistent with this, the PCAFwith Coomassie brilliant blue.
complex is capable of efficiently acetylating histones in(D) Deduced amino acid sequence of PAF65b and its alignment to
hTAFII100. Identical and related amino acids are shaded. a nucleosomal context, while the PCAF catalytic subunit
Histone-like TAFs within the PCAF Complex
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Figure 7. No Association between p300/CBP and TAFII31
A HeLa extract was immunoprecipitated with control (lane 1), anti-
PCAF (lane 2), anti-CBP (lane 3), and anti-p300 (lane 4) antibodies.
Precipitated materials were immunoblotted with a mixture of anti-
p300 and anti-CBP antibodies (top), anti-PCAF antibody (middle),
and anti-hTAFII31 antibody (bottom).
factors. It is considered that various activators recruit
TFIID through direct interaction with various TAFs (Bur-
ley and Roeder, 1996). hTAFII80 and/or the homologous
Drosophila melanogaster (d)TAFII62 (also known as
dTAFII60) interact directly with the activation domains
of p53 (Thut et al., 1995) and NFkB/p65 (Burley and
Roeder, 1996). hTAFII31 and/or the homologous dTAFII42
(also known as dTAFII40) interact with the activation
domains of p53 (Lu and Levine, 1995; Thut et al., 1995)
and VP16 (Goodrich et al., 1993). Similarly, hTAFII30 in-
teracts with the estrogen receptor (Jacq et al., 1994). In
addition to TAFs, yeast ADA/SPT proteins also interact
with transcription factors both genetically and physi-
cally. yADA2 interacts with acidic activators such asFigure 6. Similar Associated Polypeptides between the PCAF and
VP16 and GCN4 (Silverman et al., 1994; Barlev et al.,hGCN5 Complexes
1995), while ySPT3 interacts with TBP (Eisenmann et(A) Alignment of PCAF, hGCN5, and yGCN5. PCAF has a PCAF-
al., 1992). Furthermore, PCAF directly interacts with thespecific N-terminal region and a GCN5-related C-terminal region.
Note that hGCN5 also has the extended region at the N terminus transcriptional coactivators p300, CBP (Yang et al.,
(unshaded) that is not conserved in yGCN5 but is conserved in 1996), Src1 (Spencer et al., 1997), and ACTR (Chen et
PCAF. al., 1997), as well as various activators including MyoD
(B) Purification of the PCAF and hGCN5 complexes. Nuclear extracts
(Puri et al., 1997) and nuclear hormone receptors (Blancoprepared from control (lane 1), f:PCAF-expressing (lane 2), and
et al., 1998). These results suggest that the PCAF com-f:hGCN5-expressing (lane 3) HeLa cells were immunoprecipitated
plex is potentially recruited to a wide range of promoterswith anti-FLAG antibody and, subsequently, eluted with the epitope
peptide. The eluates were further purified by either anti-PCAF (lanes via multiple protein±protein interactions.
4 and 5) or anti-hGCN5 (lanes 4 and 5) antibody affinitychromatogra-
phy. The bands corresponding to f:PCAF and f:hGCN5 are marked Histone Octamer±like Structureby open and closed circles, respectively. Note that more than 50%
in the PCAF Complexof these epitope-tagged polypeptides remained on the resins after
It is thought that the histone octamer±like structure ineluting with SDS in the second affinity chromatography, while the
other polypeptides were almost completely eluted. Positions of the TFIID is composed of two dimers of the histone H2B±like
heavy and light chains of IgG are shown by asterisks. TAF (hTAFII20/hTAFII15) associated with a tetramer of
the histone H3/H4±like TAFs (hTAFII31/hTAFII80) (re-
viewed in Burley and Roeder, 1996; Hoffmann et al.,
alone weakly acetylates nucleosomal substrates (Figure 1996). Our results from yeast genetic analyses indicate
2). Taken together, these results suggest that ADA pro- that the histone H4±like TAF (yTAFII60) genetically inter-
teins may increase the efficiency of acetylation of nucleo- acts with the WD40 repeat±containing TAF (yTAFII90, a
somal substrates. homolog of hTAFII100) (M. J. Swanson and Y. N., unpub-
lished observations). These observations are supported
by biochemical interactions between the WD40 repeat±Connection between the PCAF Complex
and Transcription Factors containing TAF and histone-like TAFs (Tao et al., 1997).
These results suggest involvement of the WD40 repeat±It is quite remarkable that TAFs are not only TBP-associ-
ated factors but also PCAF- (and hGCN5-) associated containing TAF in a function of the histone-like TAFs.
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While the histone H3± and H2B±like subunits are com- p300/CBP. In this regard, subunits in the PCAF complex
may be potentially involved in cellular events mediatedmon between the PCAF and TFIID complexes, the PCAF
complex possesses unique subunits having sequence by PCAF (i.e., regulation of transcription, cell cycle pro-
gression, and differentiation). Further study of thesesimilarities to hTAFII80 and hTAFII100, namely PAF65a
and PAF65b, respectively. In light of direct interactions PCAF-associated factors should provide insights into
the molecular mechanisms of these events.between TBP and hTAFII80/hTAFII100 (reviewed in Bur-
ley and Roeder, 1996; Tao et al., 1997), these differences
may enable formation of the non±TBP-containing PCAF Experimental Procedures
complex.
A search of the complete yeast genomic database Purification of the PCAF and hGCN5 Complex
Typically, z100±200 ml of nuclear extracts were fractionated on anreveals that yeast has the histone H4±like TAF (yTAFII60)
S-Sepharose column containing z50±100 ml of resin and succes-and the WD40 repeat±containing TAF (yTAFII90), but it
sively step-eluted with 0.1 M KCl, 0.3 M KCl, and 0.5 M KCl in bufferlacks obvious counterparts of PAF65a and b. However,
B (20 mM Tris-HCl [pH 8.0]; 5 mM MgCl2; 10% glycerol; 1 mM PMSF;significantly, the SPT-ADA-GCN5 proteins genetically 0.1% Tween 20; 10 mM b-mercaptoethanol). Fractions collected
and physically interact with TBP in yeast (Eisenmann et from 0.3 M KCl elution were dialyzed against buffer B containing
al, 1992; Silverman et al., 1994; Barlev et al., 1995; Mar- 0.15 M KCl for 3 hr. Dialyzed materials were incubated with z2.5±5
ml of M2 anti-FLAG agarose (Kodak) for z4±10 hr with rotation.tens et al., 1996; Madison and Winston, 1997; Roberts
Alternatively, as in experiments shown in Figure 6, f:hGCN5 orand Winston, 1997). The ADA proteinsphysically interact
f:PCAF was immunoprecipitated directly from nuclear extracts. Afterwith various componentsof TFIID (the histone-like TAFs,
washing with z250±500 ml of buffer B containing 0.15 M KCl on a
the WD40 repeat±containing TAF, and TBP) (Drysdale et column, the bound proteins were eluted from M2 agarose by incuba-
al., 1998). In this regard, the yGCN5-containing complex tion for 60 min with z2.5±5 ml of the FLAG peptide (Kodak) in the
may utilize the histone octamer±like structure of TFIID. same buffer (0.2 mg/ml). The eluates were used for all experiments
unless specified. The M2 antibody affinity-purified materials wereIn contrast, no physical interaction is observed between
further purified by immunoprecipitation with protein A Trisacrylthe PCAF complex and TFIID (Figure 4). Thus, PAF65a
(Pierce) conjugated with anti-PCAF or anti-hGCN5 antibody. Theand b may have been acquired during metazoan evolu-
bound proteins were eluted from the matrix by incubation at room
tion, enabling the formation of complexes containing a temperature for 5 min with 20 mM Tris-HCl buffer (pH 8.0) containing
histone octamer±like structure besides TFIID. 2% SDS.
A possible role for the histone octamer±like structure
in the PCAF complex may be replacement of the histone Histone Acetylase Assay
octamer after relaxation of nucleosomal structure by Nucleosomes and core histones were isolated from HeLa cells as
acetylation of the histone tails. The basic residues at previously described (O'Neill et al., 1992). Histone acetylase assays
were performed as previously described (Ogryzko et al., 1996) withthe loop regions of core histones that interact with the
the following modifications: reactions contained 1 nmol of 14C-phosphate backbone of DNA (Luger et al., 1997) are only
actetyl CoA and 30 pmol of cores histones or nucleosomes in apartially conserved in the PCAF complex (and also in
total volume of 15 ml and incubated at 308C for 10 min. The reactions
TFIID). Thus, other domains in the PCAF complex may were stopped by the addition 5 ml of 43 SDS-PAGE sample buffer,
support DNA interaction so that the histone-like domain and 10 ml of each sample was analyzed on a 4%±20% SDS-PAGE
in the PCAF complex is able toorganize DNAin a nucleo- gel. Gels were stained with Coomassie brilliant blue, then exposed
to X-ray films.some-like manner. However, weak conservation of the
DNA-interacting residues in the PCAF complex would
provide greater accessibility of various factors to the MALDI/TOF Mass Spectrometry
A matrix-assisted laser desorption/ionization mass spectrometerDNA. Additionally, the histone-like structure may play a
with delayed extraction and a reflector (Voyager-DE STR, Perseptiverole in maintenance of the compact DNA structure after
Biosystems, Framingham, MA) was used. The working matrix solu-disruption of nucleosomes.
tion was a 2-fold dilution of a saturated solution of 2,5-dihydroxy-The histone N-terminal tails contribute to the re-
benzoic acid in acetonitrile:water (1:1). Aliquots of 0.5 ml of the
pressed chromatin state by interacting with nucleoso- peptide mixture and 0.5 ml of the working matrix solutionwere mixed
mal DNA, adjacent nucleosomes, and/or repressor pro- on the sample plate and dried in air prior to MS analysis. Masses
were calibrated internally with two peptides derived from trypsinteins (reviewed in Grunstein, 1997; Luger et al., 1997;
autolysis. Masses could be measured with better than 10 ppm massWade and Wolffe, 1997; Mizzen and Allis, 1998; Struhl,
accuracy.1998). While histone acetylases convert chromatin to
an active state by acetylating the histone tails, these
LC/ESI/MS/MSacetylated histone tails are subject to rapid deacetyla-
An electrospray ion trap mass spectrometer (LCQ, Finnigan MAT,tion by histone deacetylases (Jackson et al., 1975). An
San Jose, CA) coupled online with a capillary HPLC (Magic 2002,important feature of the histone-like domains in the
Michrom BioResources, Auburn, CA) was used to acquire MS/MS
PCAF complex (and also in TFIID) is the lack of regions spectra. An 0.2 3 20 mm MAGICMS C18 column (5 mm particle
corresponding to histone N-terminal tails. In this regard, diameter, 200 AÊ pore size) with mobile phases of A (methanol:
if it replaces the histone octamer, the histone-like struc- water:acetic acid, 5:95:1) and B (methanol:water:acetic acid,
85:15:1) was used with a gradient of 2%±98% of mobile phase Bture in the PCAF complex may play an architectural role
over 2.5 min followed by 98% B for 2 min at a flow rate of 50 ml/in the maintenance of an active chromatin state.
min. The flow was split with a Magic precolumn capillary splitterThe adenovirus E1A oncoprotein induces cell trans-
assembly (Michrom BioResources) and 3 ml/min directed to the 200
formation by targeting the p300/CBP and retinoblas-
mm column. The ion trap mass spectrometer was operated in a
toma protein families (reviewed in Moran, 1993; Nevins, data-dependent fashion during the LC run, in which the mass spec-
1994; Eckner, 1996). Our results suggest that E1A dis- trometer switched to MS/MS mode to acquire MS/MS spectra once
the intensity of a peptide ion exceeded a preset value.turbs access of the PCAFcomplex topromoters through
Histone-like TAFs within the PCAF Complex
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Immunoprecipitation and Antibodies FenyoÈ , D., Qin, J., and Chait, B.T. (1998). Protein identification using
mass spectrometric information. Electrophoresis, in press.HeLa nuclear extract (500 ml) was incubated with 2 mg of the respec-
tive antibody for 4 hr. Protein A Trisacryl (20 ml) (Pierce) was added, Goodrich, J., Hoey, T., Thut, C., Admon, A., and Tjian, R. (1993).
and incubation was continued for 1 hr with rotation. The matrix was Drosophila TAFII40 interacts with both a VP16 activation domain
washed five times with 1 ml of buffer B containing 0.15 M KCl, then and the basal transcription factor TFIIB. Cell 75, 519±530.
boiled in 20 ml of 23 SDS sample buffer. Antibodies employed are Grant, P., Duggan, L., Cote, J., Roberts, S., Brownell, J., Candau,
as follows: rabbit polyclonal antibodies against CBP (Upstate Bio- R., Ohba, R., Owen-Hughes, T., Allis, C., Winston, F., Berger, S.,
technology; #06-297 and #06-294), p300 (Santa Cruz Biotechnology; and Workman, J. (1997). Yeast Gcn5 functions in two multisubunit
#sc-584 and #sc-585), TBP (Santa Cruz Biotechnology; #sc273), complexes to acetylate nucleosomal histones: characterization of
hTAFII100, hTAFII80, hTAFII31, hTAFII20/15 (kindly provided by M. an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. 11,
Guermah, Y. Tao, andR. Roeder); and mouse monoclonalantibodies 1640±1650.
against hTAFII250 (Santa Cruz Biotechnology; #sc-735), hTAFII130 Grunstein, M. (1997). Histone acetylation in chromatin structure and
(Santa Cruz Biotechnology; # sc-736), and hTAFII30 (kindly provided transcription. Nature 389, 349±352.
by L. Tora).
Hoffmann, A., and Roeder, R. (1996). Cloning and characterization
of human TAF20/15. Multiple interactions suggest a central role in
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